Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients with Advanced Neuroendocrine Tumors

Reut Halperin, Amit Tirosh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients with Advanced Neuroendocrine Tumors'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Psychology

Immunology and Microbiology

Neuroscience